5-Minute Check In: Tumor-Infiltrating Lymphocyte Therapy in Advanced Melanoma
Released Thursday, 4th January 2024
Good episode? Give it some love!
5-Minute Check In: Tumor-Infiltrating Lymphocyte Therapy in Advanced Melanoma
5-Minute Check In: Tumor-Infiltrating Lymphocyte Therapy in Advanced Melanoma
Thursday, 4th January 2024
Good episode? Give it some love!
Rate Episode
Guest: Dr. Christopher Huerter, Professor and Division Chief Dermatology at Creighton University School of Medicine
Breakthrough treatments: Checkpoint inhibitors like Ipilimumab have changed the way we treat melanoma. Now, a new cutting-edge adoptive cell therapy with tumor-infiltrating lymphocytes (TIL) has shown promise in metastatic melanoma treatment trials. A new phase III trial compares TIL to Ipilimumab immunotherapy as first- or second-line treatment in patients with advanced melanoma with remarkable results.
Article: https://www.nejm.org/doi/full/10.1056/NEJMoa2210233
Show More
Rate
From The Podcast
5-Minute Clinical Update and Grand Rounds with Dr. Thomas McGinn
Hosted by Dr. Thomas McGinn, Professor, Baylor College of Medicine; Clinical Professor of Medicine at Creighton University School of Medicine; EVP CommonSpirit Health Physician Enterprise. Dr. McGinn brings the latest healthcare news to physicians and advanced practice providers.Join Podchaser to...
- Rate podcasts and episodes
- Follow podcasts and creators
- Create podcast and episode lists
- & much more
Episode Tags
Do you host or manage this podcast?
Claim and edit this page to your liking.
,Claim and edit this page to your liking.
Unlock more with Podchaser Pro
- Audience Insights
- Contact Information
- Demographics
- Charts
- Sponsor History
- and More!
- Account
- Register
- Log In
- Find Friends
- Resources
- Help Center
- Blog
- API
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More
- © 2024 Podchaser, Inc.
- Privacy Policy
- Terms of Service
- Contact Us